![]() |
市场调查报告书
商品编码
1756003
自动细胞样子柱器的全球市场:各产品类型,各频波带,各用途,各终端用户,各地区,机会,预测,2018年~2032年Automated Cell Shakers Market Assessment, By Product Type, By Frequency Band, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
全球自动细胞摇床市场规模预计将从2024年的7.0112亿美元增长到2032年的11.4811亿美元,预测期内(2025-2032年)的复合年增长率为6.34%。对先进实验室自动化系统日益增长的需求,在很大程度上推动了自动细胞摇床的普及。
生物技术和製药实验室以及研究中心正在推动自动细胞摇床市场的持续扩张。这些设备是细胞培养过程中必不可少的设备,透过提供可控的摇晃来优化生长环境。自动摇床透过自动化操作,性能优于手动摇床,可最大限度地减少操作员错误,并支援各种製造操作。市场发展受三大因素驱动:对细胞研发和生物製药的资金投入不断增加,以及对一致性结果的需求。
该设备具备智慧功能,支援可程式控制和即时追踪,并可与实验室资讯系统整合。北美和欧洲凭藉其发达的研究基础设施,占据市场最高水准;而亚太地区则因生物产业的扩张而推动市场成长。市场领导者正投入资源,推出将模组化元件与节能设计和容器相容性结合的新产品。由于技术进步以及在药物开发和合成生物学领域的应用不断扩展,自动细胞摇床市场持续成长。此外,各公司正在合作,以支持自动细胞摇床市场的发展。
例如,2023年5月,Cytiva Bioscience Holding Ltd. 宣布与 Pall Corporation Life Science 合作,打造全球生技创新领导者。此次合併扩展了该公司的生物加工能力,增强了其支持生物製剂和疫苗开发的能力。这项策略决策提升了公司在生技产业的市场地位,促进了创新速度和营运效率。
本报告提供全球自动细胞样子柱器市场相关调查,提供市场概要,以及各产品类型,各频波带,各用途,各终端用户,各地区趋势,及加入此市场的主要企业简介等资讯。
Global automated cell shakers market is projected to witness a CAGR of 6.34% during the forecast period 2025-2032, growing from USD 701.12 million in 2024 to USD 1148.11 million in 2032. The increasing demand for advanced laboratory automation systems is significantly boosting the adoption of automated cell shakers.
Biotechnology and pharmaceutical research laboratories, together with research centers, drive consistent market expansion for automated cell shaker equipment. These devices serve as essential instruments during cell culture operations by delivering controlled shaking to optimize growth environments. Automated shakers deliver superior performance compared to manual models through automation, which minimizes operator mistakes and supports extensive manufacturing operations. Three main factors drive market expansion: developments in cell-based research and rising biopharmaceutical funding and the requirement for consistent outcomes.
The devices enable smart functions through programmable controls and real-time tracking coupled with laboratory information system integration. The market reaches its highest level in North America and Europe because of their advanced research infrastructure, yet Asia-Pacific leads to market growth with its expanding biotech industry. The market leaders invest their resources into releasing new products that combine modular elements with energy-efficient designs and vessel compatibility. The automated cell shaker market continues to grow because of technological advancements and expanding applications in drug development and synthetic biology. Additionally, the companies are collaborating to support the automated cell shakers market.
For instance, in May 2023, Cytiva Bioscience Holding Ltd. announced a collaboration with Pall Corporation Life Science to establish a worldwide biotechnology innovation leader. The merger expanded their bioprocessing abilities, which boosted their ability to support biologics and vaccine development. The strategic decision enhanced their market standing within biotechnology, which drove both innovation speed and operational effectiveness.
Rising Demand for Cell-Based Research Boosts Market Demand
The rising demand for cell-based research in drug development, biotechnology, and regenerative medicine is significantly boosting the market shares of automated cell shakers. Cell culture applications depend on these devices to maintain uniform agitation and optimal nutrient flow, which enhances cell survival necessary for drug discovery, vaccine creation, and regenerative medicine procedures. High-throughput screening and precision-based studies within research facilities require automated cell shakers, as these devices deliver enhanced efficiency and reproducible results while minimizing contamination compared to the manual method. Programmable controls, compact designs, and lab automation integration systems drive higher adoption rates. The automated cell shaker market is expected to sustain its growth through rising R&D investments and the expansion of biological production, capturing a larger share of the life sciences equipment sector.
Additionally, the research study and clinical trials can also boost the demand for the automated cell shakers market. For instance, in March 2024, the Society for Laboratory Automation and Screening (SLAS) researched Skin Cutaneous Melanoma Prognosis, Nanoliter Droplet Handling for Enhanced Laboratory Efficiency, and other areas of life science technology. This research activity increased the demand for cell shakers.
Increasing Adoption of Laboratory Automation Drives Market Expansion
The rapid expansion of laboratory automation drives the growth of the automated cell shaker market at a fast pace. Global laboratories that strive for enhanced efficiency, accuracy, and reproducibility require automated solutions as essential tools. Automated shakers used in cell culture workflows remove operator dependence, so they minimize human mistakes while maintaining consistent shaking conditions. The need to perform high-throughput screening in drug discovery, as well as biotechnology and academic research, drives substantial market expansion. Automated systems enable laboratories to enhance process efficiency while reducing costs and boosting their productivity levels. Automated cell shakers gain market preference because technological progress enables programmable speed functions with temperature control and remote monitoring features. The market experiences fast expansion because biopharmaceutical research expands, and organizations need scalable solutions. The automated cell shaker market experiences rapid growth because laboratories pursue precision and efficiency, while new technologies emerge and laboratory automation expands across the industry. For instance, in September 2023, Kuhner Shaker launched new white versions of its LT-X(C) and ISF4-X(C) incubator shaker models, catering to aesthetic preferences and expanding their product portfolio to appeal to a broader user base. The new launches have driven laboratories to adopt automatic cell shakers because diagnostic centers now use advanced technology for enhanced quality.
Pharmaceutical Companies and Biopharmaceutical Companies Hold Largest Market Shares
Pharmaceutical and biopharmaceutical companies hold the largest market shares of the automated cell shakers market. The precise and scalable nature of automated cell shakers meet the pharmaceutical industry's rising demand for efficient cell culture processes during drug development and bioprocessing. Through automated cell shakers, companies boost their productivity levels because these devices deliver steady agitation and optimal growth conditions while minimizing contamination risks. These sectors allocate substantial capital toward purchasing modern laboratory equipment to optimize their research and production activities, to lead market expansion. The implementation of strict regulatory requirements creates an increased need for dependable automatic systems, which drives market growth. The growing biopharmaceutical market, especially those focused on biologics and cell-based treatments, strengthens this ongoing development. Pharmaceutical and biopharmaceutical companies maintain their market dominance through rapid innovation, which drives their continued adoption of automated cell shakers.
For instance, in October 2024, Eppendorf introduced the CellXpert CS220, the first CO2 incubator shaker with a built-in 180 degrees Celsius sterilisation cycle. Tailored for mammalian cell cultivation, enhanced contamination prevention, accommodated more flasks, and included a streamlined chamber for simplified cleaning. The device also showcased a compact design, delivering the highest platform-to-footprint ratio.
North America Dominates the Global Automated Cell Shakers Market Size
North America dominates the automated cell shakers market, holding the largest share due to advanced healthcare systems, the presence of major industry players, and strong research funding. The rising popularity of biopharmaceuticals, cell culture technologies, and laboratory automation drives the region's expansion. The United States leads the market due to its superior research capabilities combined with broad technological implementation and large life science capital. The growing market receives extra support for its increasing focus on drug development and regenerative medicine applications. The Canadian government supports its biotech industry through its official programs that promote development activities. Research facilities, clinical settings, and industrial labs are increasing their use of automated cell shakers to emphasize a precision medicine approach and personalized therapy development. Research organizations, together with pharmaceutical companies, create partnerships to advance technological development in North America. The regulatory systems across North America favor innovative approaches as they maintain quality standards to protect the market's leadership standing.
Furthermore, to support market expansion in this region, key players in this region are launching new products. For instance, in March 2025, Caron Scientific Inc. launched the 7406 Incubator Shaker at the EU Advanced Therapies conference. The unit featured the highest capacity in a compact footprint, H2O2 fogging sterilization, and a dry humidity control system without standing water. It offered faster turnaround, minimized contamination risks, and efficiently met GMP compliance needs.
Impact of U.S. Tariffs on the Global Automated Cell Shakers Market
The U.S. tariffs on imported merchandise specifically affect the automated cell shakers market through their impact on Chinese products. The essential biotechnology and pharmaceutical research equipment, known as automated cell shakers, needs global supply chains to achieve cost-effective production. The implementation of tariffs has driven up costs for United States buyers, decreasing the affordability of equipment for laboratory facilities and research establishments. The rising costs of imported components create pressure on the profit margins of domestic manufacturers. Businesses that need to switch to non-tariff countries for sourcing will experience supply chain disruptions because it requires both time and financial investment. Small businesses face the most significant impact from tariffs because they cannot negotiate effectively, which limits their ability to innovate. Tariffs increase the appeal of domestic production, yet the United States does not possess sufficient manufacturing capacity to fulfill market requirements. The tariffs create budget constraints while slowing research progress and generating market instability, which results in reduced market development. The current protectionist approach creates a challenging situation that may slow down the vital biotechnology sector.
Key Players Landscape and Outlook
Companies are expanding their market footprint via product development and automated system implementation, along with improved user-centered design approaches. Companies pursue their growth objectives by creating models that handle large volumes efficiently while conserving energy and by making their products compatible with laboratory automation systems. The industry shows positive prospects because AI-based optimization systems, together with remote monitoring capabilities and modular design approaches, are defining future market directions. The increasing market rivalry drives producers to develop precise, scalable products at affordable prices that match multiple laboratory requirements.
In June 2024, Thermo Fisher Scientific Inc. launched the fully integrated IntelliStack Incubator and CO2 Incubator Shakers for precise and reproducible cell culture control. The stackable units featured a 10-inch touchscreen, 5L capacity, and flexible configurations with CO2 and non-CO2 shakers. The solution targets biotech, biopharma, and academic sectors, supports automated cell therapy production, and addresses contamination risks.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.